HPV vaccine reduces cervical cancer by 87%
Back to Topic
Click to Print
Useful Websites
Glossary Term Selection
The human papillomavirus (HPV) vaccine reduces cervical cancer rates by 87% in women who were offered the jab between the ages of 12-13, confirms a new study.
Researchers from King’s found the HPV vaccination programme prevented around 450 cervical cancers and around 17,200 pre-cancers by the middle of 2019. They also found cervical cancer rates were reduced by 62% in women offered vaccination between the ages of 14-16, and 34% in women aged 16-18 when they were offered the jab.
The paper, published today in the Lancet and funded by Cancer Research UK, looked at all cervical cancers diagnosed in England in women aged 20-64 between January 2006 and June 2019. Three of these cohorts formed the vaccinated population, where women were vaccinated with Cervarix between the ages of 12-13, 14-16 and 16-18 respectively. Incidences of cervical cancer and non-invasive cervical carcinoma (CIN3) in the seven populations were recorded separately.
The vaccine programme started in England in 2008 a...
Want to see the rest of this article?
Would you like to see the rest of this article and all the other benefits that Issues Online can provide with?
- Useful related articles
- Video and multimedia references
- Statistical information and reference material
- Glossary of terms
- Key Facts and figures
- Related assignments
- Resource material and websites
